MYOS Insider Trading Activity and SEC Form 4 Filings
MYOS insider trading summary
No open-market insider purchases or sales of Myos Rens Technology Inc. (MYOS) have been reported on SEC Form 4 in the past 12 months.
Latest MYOS insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Mar 31, 2020 | Andrew Joel Ponte | Director | Buy | $0 (3,306 @ $0.00) |
| Mar 31, 2020 | Joseph Mannello | Chief Executive Officer | Buy | $0 (16,529 @ $0.00) |
| Mar 31, 2020 | Christopher C Dewey | Director | Buy | $0 (6,611 @ $0.00) |
| Mar 6, 2020 | David J Matlin | 10% Owner | Buy | $250K (206,611 @ $1.21) |
| Mar 5, 2020 | Joseph Mannello | Chief Executive Officer | Buy | $825K (681,818 @ $1.21) |
| Mar 5, 2020 | Christopher Pechock | Director | Buy | $100K (82,645 @ $1.21) |
| Mar 5, 2020 | Andrew Joel Ponte | Director | Buy | $100K (82,645 @ $1.21) |
| Mar 5, 2020 | Christopher C Dewey | Director | Buy | $100K (82,645 @ $1.21) |
| Mar 27, 2019 | Joseph Mannello | Chief Executive Officer | Buy | $250K (171,233 @ $1.46) |
| Mar 27, 2019 | Christopher Pechock | Director | Buy | $50K (34,247 @ $1.46) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.